At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we never stop working to create a future where disease is a thing of the past. We tackle society’s most pressing health challenges, connecting big ideas to the resources we need to make them a reality. Our goal is to advance access
to good health for all. By seeking out medical breakthroughs wherever they occur, leveraging internal expertise and embracing external science, we aim to bring the best solutions to the people who need them.

The complex, global healthcare landscape presents new challenges, new diseases and new dynamics. That’s why we focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives. We must work together – across business, academia, governments and society – to lead healthcare’s ongoing reinvention. At Janssen, we collaborate with the world for the health of everyone in it.

To learn more, visit our website: www.janssen.com


Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, Zika and norovirus. The Takeda team brings an outstanding track record and a wealth of knowledge in vaccine development, manufacturing and global access to advance a pipeline of vaccines to address some of the world’s most pressing public health needs.